First Trust Advisors LP Palatin Technologies Inc Transaction History

First Trust Advisors LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$0.44 - $0.63 $236,434 - $338,531	-537,351 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$0.48 - $0.72 $9,287 - $13,931	-19,349 Reduced 3.48%	537,351 $328,000
Q1 2021 May 14, 2021	BUY	$0.68 - $1.25 $30,585 - $56,223	44,979 Added 8.79%	556,700 $384,000
Q4 2020 Feb 02, 2021	SELL	$0.38 - $0.78 $8,220 - $16,872	-21,632 Reduced 4.06%	511,721 $346,000
Q3 2020 Nov 05, 2020	BUY	$0.47 - $0.64 $45,426 - $61,857	96,653 Added 22.13%	533,353 $252,000

Q2 2020 Jul 22, 2020	BUY	$0.41 - $0.73 $12,741 - $22,685	31,076 Added 7.66%	436,700 $224,000
Q1 2020 May 06, 2020	SELL	$0.36 - $0.79 $28,318 - $62,142	-78,662 Reduced 16.24%	405,624 $172,000
Q4 2019 Feb 03, 2020	BUY	$0.75 - $0.89 $14,802 - $17,565	19,737 Added 4.25%	484,286 $379,000
Q3 2019 Nov 04, 2019	BUY	$0.78 - $1.09 $362,348 - $506,358	464,549 New	464,549 $422,000

3.02K

Ticker PTN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,290,480
Market Cap $17.5M
Description
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

Stay updated on First Trust Advisors LP with notifications on news.